pLVET-tTR-KRAB Citations (5)
Originally described in: A versatile tool for conditional gene expression and knockdown.Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P Nat Methods. 2006 Feb . 3(2):109-16. PubMed Journal
Articles Citing pLVET-tTR-KRAB
Articles |
---|
Multipurpose modular lentiviral vectors for RNA interference and transgene expression. Kesireddy V, van der Ven PF, Furst DO. Mol Biol Rep. 2010 Jul;37(6):2863-70. doi: 10.1007/s11033-009-9840-8. Epub 2009 Oct 2. PubMed |
Lentiviral vector-mediated transgenesis in human embryonic stem cells. Du ZW, Zhang SC. Methods Mol Biol. 2010;614:127-34. doi: 10.1007/978-1-60761-533-0_8. PubMed |
Inhibition of the CXCR3-mediated pathway suppresses ultraviolet B-induced pigmentation and erythema in skin. Kurata R, Fujita F, Oonishi K, Kuriyama KI, Kawamata S. Br J Dermatol. 2010 Sep;163(3):593-602. doi: 10.1111/j.1365-2133.2010.09850.x. Epub 2010 May 11. PubMed |
LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming. Ren B, Best B, Ramakrishnan DP, Walcott BP, Storz P, Silverstein RL. Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1197-208. doi: 10.1161/ATVBAHA.116.307421. Epub 2016 Mar 24. PubMed |
Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with alphaV-Class integrins to promote EMT.
Zhang K, Myllymaki SM, Gao P, Devarajan R, Kytola V, Nykter M, Wei GH, Manninen A.
Oncogene. 2017 Oct 12;36(41):5681-5694. doi: 10.1038/onc.2017.177. Epub 2017 Jun 12.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.